SAMANTHA SMART: Open Payments
NPI 1053869271 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 60 payments from 19 companies in 2025. Trend: 2023 $2,341 · 2024 $1,717 · 2025 $1,218
Food & beverage: $1,218
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $147 |
| PFIZER INC. | 10 | $144 |
| Boston Scientific Corporation | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $96 |
| ABBVIE INC. | 5 | $92 |
| Lilly USA, LLC | 5 | $85 |
| Amgen Inc. | 5 | $73 |
| Dexcom, Inc. | 2 | $72 |
| Janssen Pharmaceuticals, Inc | 4 | $69 |
Products named: REXULTI, LUX-Dx Insertable Cardiac Monitor, NURTEC ODT, XIFAXAN, MOUNJARO, Ozempic, Dexcom G6 Transmitter, SPRAVATO.
Industry payments across VA — which companies pay providers there.
